INO 8-K 2026-11-02

INOVIO PHARMACEUTICALS, INC. (INO) 8-K dated 2026-11-02 — accession 0001193125-26-442648.

INOVIO PHARMACEUTICALS, INC. (INO) is a biotechnology company listed on US.

INOVIO PHARMACEUTICALS, INC. filed a 8-K on 2026-11-02. Accession 0001193125-26-442648.

This 8-K covers: Reg FD disclosure (Item 7.01), Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported INO revenue for 2025-12-31 was $65.3K. Net income was -$84.9M. Revenue was down 70.0% from 2024-12-31 to 2025-12-31. INO currently screens at market cap $88.0M.

Not investment advice. The INO SEC hub lists recent forms. The stock page is the research view.